MannKind to Participate in Upcoming Investor Conferences

Core Insights - MannKind Corporation will participate in two upcoming investor conferences, with CEO Michael Castagna and CFO Chris Prentiss engaging in discussions and meetings with investors [1][2]. Group 1: Conference Details - MannKind will attend the Leerink Partners 2026 Global Healthcare Conference in Miami on March 10 at 3:40 p.m. ET [2]. - The company will also be present at the Barclays 28th Annual Global Healthcare Conference in Miami on March 11 at 1:00 p.m. ET [2]. - Live audio webcasts of the sessions will be available on MannKind's website, with recorded versions accessible for approximately 90 days post-conference [2]. Group 2: Company Overview - MannKind Corporation is a biopharmaceutical company focused on transforming chronic disease care through innovative, patient-centric solutions [3]. - The company specializes in cardiometabolic and orphan lung diseases, developing treatments for serious unmet medical needs such as diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease [3]. - MannKind has expertise in drug-device combinations, aiming to deliver therapies that integrate seamlessly into patients' daily lives [4].